These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2740170)

  • 21. Evaluation of the febrile infant younger than 3 months of age with no source of infection.
    Nozicka CA
    Am J Emerg Med; 1995 Mar; 13(2):215-8. PubMed ID: 7893312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
    Sard B; Bailey MC; Vinci R
    Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of impact of CRP rapid test in management of febrile children in ambulatory pediatric practice].
    Cohen R; Lécuyer A; Wollner C; Deberdt P; Thollot F; Henriquet V; de La Rocque F
    Arch Pediatr; 2008 Jun; 15(6):1126-32. PubMed ID: 18486458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult bacteremia and septicemia in the febrile child younger than two years.
    Singer JI; Vest J; Prints A
    Emerg Med Clin North Am; 1995 May; 13(2):381-416. PubMed ID: 7737026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial evaluation for and management of bacteremia and bacterial meningitis in infants.
    Fulginiti VA
    Emerg Med Clin North Am; 1983 Apr; 1(1):101-11. PubMed ID: 6394281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine testing in young febrile children: a risk-benefit analysis.
    Kramer MS; Tange SM; Drummond KN; Mills EL
    J Pediatr; 1994 Jul; 125(1):6-13. PubMed ID: 8021786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of cerebrospinal fluid pleocytosis in febrile infants aged 0 to 90 days.
    Meehan WP; Bachur RG
    Pediatr Emerg Care; 2008 May; 24(5):287-93. PubMed ID: 18496111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of occult bacteremia: a prospective randomized clinical trial.
    Carroll WL; Farrell MK; Singer JI; Jackson MA; Lobel JS; Lewis ED
    Pediatrics; 1983 Nov; 72(5):608-12. PubMed ID: 6356004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of informed consent principles in the emergency department evaluation of febrile children at risk for occult bacteremia.
    Yamamoto LG
    Hawaii Med J; 1997 Nov; 56(11):313-7, 320-2. PubMed ID: 9420350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive Kingella kingae infections in children: clinical and laboratory characteristics.
    Dubnov-Raz G; Scheuerman O; Chodick G; Finkelstein Y; Samra Z; Garty BZ
    Pediatrics; 2008 Dec; 122(6):1305-9. PubMed ID: 19047250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative importance of bacteremia and viremia in the course of acute fevers of unknown origin in outpatient children.
    Murray DL; Zonana J; Seidel JS; Yoshimori RN; Imagawa DT; St Geme JW
    Pediatrics; 1981 Aug; 68(2):157-60. PubMed ID: 7267220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age inconsistency in the American Academy of Pediatrics guidelines for acute otitis media.
    Meropol SB; Glick HA; Asch DA
    Pediatrics; 2008 Apr; 121(4):657-68. PubMed ID: 18381528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of febrile children in a paediatric emergency department.
    Osman O; Brown D; Beattie T; Midgley P
    Health Bull (Edinb); 2002 Jan; 60(1):33-9. PubMed ID: 12664766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
    Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
    Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and cost-effectiveness.
    Lieu TA; Schwartz JS; Jaffe DM; Fleisher GR
    J Pediatr; 1991 Jan; 118(1):21-9. PubMed ID: 1898749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revising the decision analysis for febrile children at risk for occult bacteremia in a future era of widespread pneumococcal immunization.
    Yamamoto LG
    Clin Pediatr (Phila); 2001 Nov; 40(11):583-94. PubMed ID: 11758957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of infants at risk for occult bacteremia: a decision analysis.
    Downs SM; McNutt RA; Margolis PA
    J Pediatr; 1991 Jan; 118(1):11-20. PubMed ID: 1986075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of child with fever without source: review of literature and update.
    Arora R; Mahajan P
    Pediatr Clin North Am; 2013 Oct; 60(5):1049-62. PubMed ID: 24093895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fever without a focus in children 0-36 months of age].
    Kuzmanović S; Roncević N; Stojadinović A
    Med Pregl; 2006; 59(3-4):187-91. PubMed ID: 17066595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood cultures in the management of febrile outpatients later found to have bacteremia.
    Alario AJ; Nelson EW; Shapiro ED
    J Pediatr; 1989 Aug; 115(2):195-9. PubMed ID: 2787855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.